Open Label Trial of Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in Children with 22q11.2 Deletion Syndrom (22qDS)

Project: Research

Project Details

StatusFinished
Effective start/end date31/01/201230/07/2013